Search

everythinglearnresearchcommunity

for

Search:↓

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

A new genetic variant causes BRESHECK syndrome by disrupting cell growth and stress response.

New mutations in MBTPS2 reduce its function and cause IFAP syndrome with unusual symptoms.

Pseudofolliculitis barbae is a chronic skin condition affecting mainly African American and Hispanic individuals, caused by shaving tightly curled hair, and managed by prevention and treatment but not curable.

Disrupting the FGF5 gene in rabbits leads to longer hair by extending the hair growth phase.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

PFOS exposure disrupts hormone levels and enzyme activities in juvenile frogs, affecting males and females differently.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

The flaky skin mouse mutation is a natural model for studying human psoriasis.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

The Protein-Sparing Modified Fast is effective for rapid weight loss and maintaining it, but requires medical supervision and can have side effects.

BFNB could be a promising treatment for hair growth.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

Fibrodysplasia ossificans progressiva is a rare genetic disorder that causes extra bone growth and symptoms of premature aging.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

Certain genetic variations in IGF2BP2 and IGFBP3 are linked to a higher risk of PCOS.

Fetuin-A levels are higher in PCOS patients, suggesting it may play a role in the condition.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Finasteride caused blisters on hands and feet.

Finasteride increases P-glycoprotein activity in the liver and kidney.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.